Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETO2X-bio: Oxygen in Suspected AMI
NCT02290080Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxygen in acute myocardial infarction (AMI) and acute coronary syndrome (ACS) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Plasma concentration levels over time of biomarkers of oxidative stress, apoptosis, inflammation and platelet aggregation. Started Oct 2014; status: completed.
02
Drugs
oxygen
03
Conditions
acute myocardial infarction (AMI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02290080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290080.